Advertisement
Loading...

Compugen Ltd.

CGEN•NASDAQ
Healthcare
Biotechnology
$3.03
$0.18(6.32%)
U.S. Market opens in 16h 39m

Compugen Ltd. (CGEN) Stock Overview

Explore Compugen Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap286.5M
P/E Ratio7.55
EPS (TTM)$0.38
ROE0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$1.52
3 Months$1.49
1 Year Target$1.48

CGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Compugen Ltd. (CGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.55 and a market capitalization of 286.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.32%
5-Day Change
4.48%
1-Month Change
5.21%
3-Month Change
83.64%
6-Month Change
84.76%
Year-to-Date (YTD) Change
98.04%
1-Year Change
131.30%
3-Year Change
272.05%
5-Year Change
-62.13%
All-Time (Max) Change
-72.76%

Contact Information

https://cgen.com
972 3 765 8585
Azrieli Center, Holon, NaN, 5885849

Company Facts

74 Employees
IPO DateAug 11, 2000
CountryIL
Actively Trading

Frequently Asked Questions